Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021)
Cytek Biosciences (CTKB) posted Preferred Dividend Payments of -$1.2 million for Q4 2021, down 210.89% on a QoQ basis from $1.1 million in Q3 2021, and down 104.35% year-over-year from $27.4 million in Q4 2020.
Cytek Biosciences (CTKB) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Cytek Biosciences' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at -$1.2 million for Q4 2021.
- Quarterly Preferred Dividend Payments fell 104.35% year-over-year to -$1.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was -$1.2 million (down 103.98% YoY) and the FY2021 annual result came in at $3.0 million, down 81.47% from the prior year.
- Preferred Dividend Payments was -$1.2 million for Q4 2021 at Cytek Biosciences, down from $1.1 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $27.4 million in Q4 2020 and bottomed at -$6.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.19 Mn |
| Sep 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 2.67 Mn |
| Dec 31, 2020 | 27.37 Mn |
| Sep 30, 2020 | -5.09 Mn |
| Jun 30, 2020 | -6.21 Mn |